• No results found

University of Groningen Multicomponent reactions, applications in medicinal chemistry & new modalities in drug discovery Konstantinidou, Markella

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Multicomponent reactions, applications in medicinal chemistry & new modalities in drug discovery Konstantinidou, Markella"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Multicomponent reactions, applications in medicinal chemistry & new modalities in drug discovery

Konstantinidou, Markella

DOI:

10.33612/diss.111908148

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Konstantinidou, M. (2020). Multicomponent reactions, applications in medicinal chemistry & new modalities in drug discovery. Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.111908148

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

539629-L-sub02-st-Markella 539629-L-sub02-st-Markella 539629-L-sub02-st-Markella 539629-L-sub02-st-Markella

PROPOSITIONS

for the thesis

Multicomponent reactions, applications in medicinal chemistry

& new modalities in drug discovery

Markella Konstantinidou

1. Multicomponent reaction chemistry (MCR) can be utilized for the synthesis of natural products, diverse heterocycles and has applications in medicinal chemistry.

2. MCR scaffolds are tolerating numerous post-modifications, allowing the synthesis of complex scaffolds in a few synthetic steps.

3. The clinical success of monoclonal antibodies targeting the PD-1 / PD-L1 axis has revived the field of immune-oncology.

4. The scaffold of 1,3,4-oxadiazoles has various applications in the fields of medicinal chemistry and is considered a bioisostere for amides.

5. Employing computational tools in drug discovery significantly accelerates the procedure and reduces the synthetic effort, by synthesizing only the most promising hits.

6. Proteolysis targeting chimeras are revolutionizing traditional concepts in medicinal chemistry and are changing the paradigm of “undruggable” targets. 7. Projects described as “low-hanging fruits” bear a lot of similarities with unicorns;

no-one has actually encountered them but their existence cannot be ruled out entirely.

8. “I am among those who think that science has great beauty. A scientist in his laboratory is not only a technician, he is also a child placed before natural phenomena, which impress him like a fairy tale.” [Marie Skłodowska- Curie] 9. ‘’ To every problem, there is a most simple solution.’’ [Agatha Christie] 10. Never stop learning.

Referenties

GERELATEERDE DOCUMENTEN

Advanced techniques such as radiotracers for immunoPET imaging of PD-1 checkpoint expression on tumor-infiltrating lymphocytes and PD-L1 in general might therefore become

The co-crystal structure of human PD-1 and PD-L1 is expected to be a valuable starting point for the design of novel inhibitors, along with the recent crystal structures

Then, the solvent was removed under reduced pressure and the crude reaction mixture was purified by column chromatography (eluent: PE – EA [0 to 100% EtOAc in PE]).. For

With the optimized one-pot reaction conditions in hand, the scope of the “Ugi-4CR/cyclization” reaction was further investigated by reacting propargylamine with

A Ugi 4-component reaction with indole-2-carboxylic acid and an aniline followed by a Pd-catalyzed cyclization yields tetracyclic indoloquinolines in good to moderate

The reaction mixture was stirred at room temperature for 24 h to obtain intermediates A; then the solvent was removed and acetic anhydride [0.5 M] and 4N HCl in dioxane (1.0

After the completion of the reaction, the mixture was concentrated under reduced pressure and in the residue was added aryl chloride 6 (0.75 mmol), pyridine (1 ml) and the

The catalytic dyad (D35 and D 219) is represented by stick models. Oxygen atoms are colored in red and nitrogen atoms in blue. On the right, close-up view of the accommodation